1. Home
  2. WHWK vs HYFT Comparison

WHWK vs HYFT Comparison

Compare WHWK & HYFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WHWK
  • HYFT
  • Stock Information
  • Founded
  • WHWK 2007
  • HYFT 1983
  • Country
  • WHWK United States
  • HYFT United States
  • Employees
  • WHWK N/A
  • HYFT N/A
  • Industry
  • WHWK Biotechnology: Pharmaceutical Preparations
  • HYFT Biotechnology: Pharmaceutical Preparations
  • Sector
  • WHWK Health Care
  • HYFT Health Care
  • Exchange
  • WHWK Nasdaq
  • HYFT Nasdaq
  • Market Cap
  • WHWK 90.0M
  • HYFT 80.8M
  • IPO Year
  • WHWK N/A
  • HYFT 2017
  • Fundamental
  • Price
  • WHWK $2.19
  • HYFT $1.87
  • Analyst Decision
  • WHWK
  • HYFT
  • Analyst Count
  • WHWK 0
  • HYFT 0
  • Target Price
  • WHWK N/A
  • HYFT N/A
  • AVG Volume (30 Days)
  • WHWK 133.0K
  • HYFT 1.5M
  • Earning Date
  • WHWK 11-15-2025
  • HYFT 09-15-2025
  • Dividend Yield
  • WHWK N/A
  • HYFT N/A
  • EPS Growth
  • WHWK N/A
  • HYFT N/A
  • EPS
  • WHWK N/A
  • HYFT N/A
  • Revenue
  • WHWK $21,596,000.00
  • HYFT $18,214,531.00
  • Revenue This Year
  • WHWK N/A
  • HYFT $19.93
  • Revenue Next Year
  • WHWK N/A
  • HYFT $32.15
  • P/E Ratio
  • WHWK N/A
  • HYFT N/A
  • Revenue Growth
  • WHWK N/A
  • HYFT 18.33
  • 52 Week Low
  • WHWK $1.39
  • HYFT $0.27
  • 52 Week High
  • WHWK $3.81
  • HYFT $3.25
  • Technical
  • Relative Strength Index (RSI)
  • WHWK 78.67
  • HYFT N/A
  • Support Level
  • WHWK $1.85
  • HYFT N/A
  • Resistance Level
  • WHWK $1.97
  • HYFT N/A
  • Average True Range (ATR)
  • WHWK 0.10
  • HYFT 0.00
  • MACD
  • WHWK 0.03
  • HYFT 0.00
  • Stochastic Oscillator
  • WHWK 88.64
  • HYFT 0.00

About WHWK Whitehawk Therapeutics Inc. Common Stock

Whitehawk Therapeutics Inc is a preclinical stage oncology therapeutics. The company is engaged in applying technologies to established tumor biology to efficiently deliver improved cancer treatments. The company's three-asset ADC portfolio is engineered to overcome the limitations of first-generation predecessors to deliver a meaningful impact for patients with difficult-to-treat cancers.

About HYFT MindWalk Holdings Corp. Common Stock

MindWalk Holdings Corp is a Bio-Native AI company transforming drug discovery and development. Powered by patented HYFT technology and the LensAI platform, MindWalk unifies sequence, structure, function, and literature into a single computational language and closes the loop with an integrated, full-stack wet lab. The platform supports rapid epitope mapping, de novo molecular design, in silico vaccine exploration, and population-scale biologics analytics that help turn insights into validated candidates at speed.

Share on Social Networks: